This activity is supported by an educational grant from Astellas Scientific and Medical Affairs, Inc.
Managed Care's Role in Improving Adherence and Outcomes in Solid Organ Transplantation: A CE/CME Supplement to The American Journal of Managed Care
Cher Enderby, PharmD, BCPS, BCNSP
Department of Pharmacy
Cesar A. Keller, MD
Professor of Medicine
Medical Director, Lung Transplant Program
A. Scott Mathis, PharmD
Director of Pharmacy
Monmouth Medical Center
Long Branch, New Jersey
Priya H. Karkhanis, MSM
Hillsborough, New Jersey
This supplement to The American Journal of Managed Care
is intended to provide an understanding of solid organ transplantation as it relates to improving long-term graft survival. Included are the most recent data on transplant types and their outcomes, approaches to managing immunosuppression and its adverse effects, data on cost-effectiveness of transplantation, and strategies to improve adherence.
Upon completion of this activity, participants should be able to:
Identify screening criteria used to efficiently register candidates for solid organ transplantation
Summarize the immunosuppressive options for recipients of solid organ transplants
List common adverse effects of medications used after solid organ transplantation
Identify common barriers to adherence in transplant recipients
Review the role of managed care in promoting successful transplant outcomes
Managed care clinicians and administrators, including physicians, pharmacists, medical and formulary directors, and other managed care professionals involved in the management and care of patients who have received an organ transplant.
January 15, 2015
January 15, 2016
Estimated time to complete activity:
Type of activity:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accredita tion Council for Continuing Medical Education (ACCME) through the joint providership of the Penn State College of Medicine and Pharmacy Times Office of Continuing Professional Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Penn State College of Medicine designates this enduring material activity for a maximum of 3.0 AMA PRA Category 1 Credits
™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 3.0 contact hours (0.30 CEUs) under the ACPE universal activity number 0290-9999-15-002-H01-P. The activity is available for CE credit through January 15, 2016.
Important Instructions for Obtaining CPE Credit:
To receive a Statement of Credit, participants must complete the pretest, read the article in its entirety and complete the online evaluation and post-test with a score of 70% or better. After successful completion and submission of the online posttest and activity evaluation your credit will be uploaded to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net.
All steps must be completed in order to receive credit. Please ensure your Pharmacy Times account is updated with your NABP e-profile number and your date of birth (MMDD format). Participation data will not be uploaded into CPE MonitorTM if you do not have your NABP e-profile number and date of birth entered into your profile on www.pharmacytimes.org.
According to the disclosure policy of the Penn State College of Medicine, all persons who are in a position to control content are required to disclose any relevant financial relationships with commercial interests. If a conflict is identified, it is the responsibility of the Penn State College of Medicine and Pharmacy Times Office of Continuing Profession Education to initiate a mechanism to resolve the conflict(s). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
Drs Enderby, Keller, and
Ms Karkhanis have no relevant commercial financial relationships or affiliations to disclose.
The American Journal of Managed Care
—Jeff D. Prescott, PharmD, RPh, and Ida Delmendo have no relevant financial relationships with commercial interests to disclose.
Penn State College of Medicine
Planning staff and faculty involved in the development and review of this activity have no relevant financial relationships with commercial interests to disclose.
Pharmacy Times Office of Continuing Professional Education
—David Heckard; Steve Lin, PharmD, RPh; Donna Fausak; and Nathalie Harden have no relevant financial relationships with commercial interests to disclose.
Disclosure of Unapproved/Off-Label Use
The contents of this activity may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Participants should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products
The information provided in this CE/CME activity is for continuing medical and pharmacy education purposes only and is not meant to substitute for the independent medical or pharmacy judgment of a physician or pharmacist relative to diagnostic, treatment, or management options for a specific patient’s medical condition.
The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of The American Journal of Managed Care
, Pharmacy Times Office of Continuing Professional Education, and Penn State College of Medicine, or any of the companies that provided commercial support for this CE/CME activity.